(Q40587497)

21 September 2017

1 reference

title

Antiendotoxin monoclonal antibodies. What future now? (English)

1 reference

21 September 2017

G M Susla

1

1 reference

21 September 2017

R B Dew

series ordinal

2

1 reference

21 September 2017

publication date

1 October 1994

1 reference

21 September 2017

1 reference

21 September 2017

volume

11

1 reference

21 September 2017

issue

4

1 reference

21 September 2017

page(s)

215-222

1 reference

Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

21 September 2017

cites work

1 reference

12 December 2020

Pathogenetic mechanisms of septic shock

1 reference

12 December 2020

Septic shock: pathogenesis

1 reference

12 December 2020

Lipopolysaccharides: structural principles and biologic activities

1 reference

12 December 2020

Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock

1 reference

12 December 2020

Control of endotoxin activity and interleukin-1 production through regulation of lipopolysaccharide-lipoprotein binding by a macrophage factor

1 reference

12 December 2020

Anti-endotoxin monoclonal antibodies

1 reference

12 December 2020

Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock

1 reference

12 December 2020

STUDIES ON BACILLUS TYPHOSUS TOXIC SUBSTANCES : I. PHENOMENON OF LOCAL SKIN REACTIVITY TO B. TYPHOSUS CULTURE FILTRATE.

1 reference

12 December 2020

The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin

1 reference

12 December 2020

Passive immunization against the local Shwartzman reaction

1 reference

12 December 2020

Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987.

1 reference

12 December 2020

HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis

1 reference

12 December 2020

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

12 December 2020

Type-Specific and Cross-Reactive Antibodies in Gram-Negative Bacteremia

1 reference

12 December 2020

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

1 reference

12 December 2020

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

12 December 2020

Endotoxins and disease mechanisms

1 reference

12 December 2020

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

1 reference

12 December 2020

Endotoxin in septic shock

1 reference

12 December 2020

Bacterial endotoxins: chemical structure, biological activity and role in septicaemia

1 reference

12 December 2020

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

1 reference

12 December 2020

Cytokines and sepsis: pathophysiology and therapy.

1 reference

12 December 2020

Endotoxemia in human septic shock

1 reference

12 December 2020

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

12 December 2020

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

12 December 2020

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

12 December 2020

1 reference

12 December 2020

Modern views on inflammation

1 reference

12 December 2020

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

12 December 2020

Introduction of new technology into critical care practice: a history of HA-1A human monoclonal antibody against endotoxin.

1 reference

12 December 2020

Antiendotoxin therapies for septic shock.

1 reference

12 December 2020

Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Anti-lipopolysaccharide antibodies measured by enzyme-immunoassay in Danish blood donors.

1 reference

12 December 2020

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies

1 reference

12 December 2020

Immunotherapy with antibodies to core lipopolysaccharide: a critical appraisal

1 reference

12 December 2020

Endotoxin as a therapeutic target in septic shock

1 reference

12 December 2020

Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis

1 reference

12 December 2020

Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes

1 reference

12 December 2020

Detection of endotoxin in the blood of patients with sepsis due to gram-negative bacteria

1 reference

12 December 2020

Pathogenesis and potential strategies for prevention and treatment of septic shock: an update

1 reference

12 December 2020

Monoclonal antibodies and the treatment of gram-negative bacteremia and shock

1 reference

12 December 2020

A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis.

1 reference

12 December 2020

Limitations of the Usefulness of the Limulus Assay for Endotoxin

1 reference

12 December 2020

A direct enzyme-linked immunosorbent assay (ELISA) for antibodies to enterobacterial Re core glycolipid and lipid A. Results in healthy subjects and in patients infected by gram-negative bacteria.

1 reference

12 December 2020

Structure and function of lipopolysaccharide binding protein

1 reference

12 December 2020

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

12 December 2020

Use of novel therapeutic agents for the treatment of serious infection

1 reference

12 December 2020

Endotoxaemia: an early predictor of septicaemia in febrile patients

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide

1 reference

12 December 2020

Role of endotoxin and host cytokines in septic shock

1 reference

12 December 2020

10.2165/00002018-199411040-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

21 September 2017

1035938247

0 references

1 reference